Healing ALS Registry Observational Study (HAROS)
NCT07233148 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-01-28
Summary
This is a prospective, observational, online study of people diagnosed with ALS, MND or PLS referred to as HAROS (Healing ALS Registry Observational Study). Participants will enter information into an online ALS registry once per month, including their ALSFRS-R data, certain other symptoms, dietary intake, supplements, medications and other therapies, both conventional and integrative. Participants will also enter the hours spent on optional self-study and free online education. The investigators will assess the effectiveness of various therapies and education by measuring physical outcomes.
Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Motor Neuron Disease (MND)
- Primary Lateral Sclerosis (PLS)
Interventions
- OTHER
-
Education about treatment options
Education about treatment options and integrative therapies is optional. It is available online and is free for all study participants.
- DIETARY_SUPPLEMENT
-
Dietary Supplements: Vitamins, Minerals, Herbs, etc.
The investigators are observing type and quantity of dietary supplements, vitamins, minerals and herbs that ALS/MND/PLS patients take regularly.
- BEHAVIORAL
-
Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc.
Many of those diagnosed with ALS/MND/PLS regularly engage in meditation, prayer and other behavioral protocols. These will be observed and analyzed to see if, and to what degree they affect outcomes.
- OTHER
-
Diet, various diets will be observed
May ALS/MND/PLS patients follow a specific diet such as ketogenic, vegetarian, gluten-free, dairy-free, and/or sugar-free. The investigators will analyze which diets are most efficacious.
- OTHER
-
Exercise, physical therapy, occupational therapy, speech therapy, sauna, EMS, massage and other therapies
Exercise, physical therapy, occupational therapy, speech therapy, sauna, massage, EMS (electro-muscular stimulation), red light therapy and other physical modalities will be observed and analyzed for effect on outcomes.
- DRUG
-
ALS medications and other medications
Many ALS/MND/PLS patients find benefit from prescription and other drugs. These will be observed and analyzed for effect on quality of life and outcomes.
- OTHER
-
Physical and emotional support
Study participants are asked to record the level of emotional and physical support they get from family members, caregivers, friends, medical professionals and members of their community. The investigators will analyze how the perceived level of emotional and physical support affect outcomes.
Sponsors & Collaborators
-
Healing Advocates Registry and Ministry
lead OTHER
Principal Investigators
-
William L Cowden, MD · Chair of Scientific Board of Academy of Comprehensive Integrative Medicine, Co-chair of Medical Advisory Team of Healing ALS
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-26
- Primary Completion
- 2036-02-05
- Completion
- 2036-03-31
Countries
- United States
Study Locations
More Related Trials
-
ALS Research Collaborative
NCT06885918 ·Status: RECRUITING
-
LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS
NCT07312240 ·Status: RECRUITING ·Phase: NA
-
Analysis of Human ALS Tissues and Registry of ALS Patients
NCT05067179 ·Status: RECRUITING
-
Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis
NCT01992029 ·Status: TERMINATED
-
ALS/MND Natural History Study Data Repository
NCT05966038 ·Status: RECRUITING
-
Answer ALS: Individualized Initiative for ALS Discovery
NCT02574390 ·Status: COMPLETED
-
Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis
NCT02447952 ·Status: COMPLETED ·Phase: NA
-
Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes
NCT06771414 ·Status: NOT_YET_RECRUITING
-
Intermediate-Sized Expanded Access Study
NCT05597436 ·Status: NO_LONGER_AVAILABLE
-
PREVENT ALL ALS Study
NCT06581861 ·Status: RECRUITING
-
Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT05949294 ·Status: WITHDRAWN ·Phase: PHASE1
-
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS
NCT02017912 ·Status: COMPLETED ·Phase: PHASE2
-
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS
NCT06917924 ·Status: RECRUITING
-
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
NCT02327845 ·Status: ENROLLING_BY_INVITATION
-
Spinal Interneuron Excitability in ALS
NCT02429492 ·Status: COMPLETED ·Phase: NA
-
ASSESS ALL ALS Study
NCT06578195 ·Status: RECRUITING
-
Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
NCT02152449 ·Status: COMPLETED ·Phase: NA
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
A Longitudinal Analysis of Biomarkers in Patients With ALS
NCT05309408 ·Status: UNKNOWN
-
Evaluation of Palliative Care for Patients With ALS and Their Caregivers
NCT04257760 ·Status: COMPLETED ·Phase: NA
-
Study of Predictive Factors of Progression of Motor Neurone Disease
NCT02360891 ·Status: COMPLETED
-
Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)
NCT05276349 ·Status: COMPLETED
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
Repeated Mesenchymal Stem Cell Injections in ALS
NCT04821479 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identification of Early Markers for ALS
NCT07213440 ·Status: RECRUITING ·Phase: NA